3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
6
Unknown
2
Terminated
2
Withdrawn
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Prostatic Neoplasms
240
Carcinoma, Renal Cell
75
Urinary Bladder Neoplasms
56
Kidney Neoplasms
32
Breast Neoplasms
26
Neoplasms
25
Carcinoma, Transitional Cell
22
Neoplasm Metastasis
21
Carcinoma, Non-Small-Cell Lung
14
Sarcoma
11
Non-Muscle Invasive Bladder Neoplasms
11
Lung Neoplasms
11
Melanoma
10
Wilms Tumor
8
Testicular Neoplasms
8
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
7
Urologic Neoplasms
7
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Small Cell Lung Carcinoma
6
Recurrence
6
Ovarian Neoplasms
6
Endometrial Neoplasms
6
Carcinoma, Hepatocellular
6
Carcinoma
6
Prostatic Neoplasms, Castration-Resistant
5
Neuroblastoma
5
Esophageal Neoplasms
5
Interventions
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Metabolic Syndrome
×
Genitourinary
×
Clear all
NCT03173807
2017-10-06
ProNEST
University of Pittsburgh
Phase NA
Withdrawn